Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Tina Tan
On this week's podcast, we discuss our latest MTI 100 rankings, providing a view on top revenue-getters in the medtech space, and we look at issues that are driving up and down movements on the list.
Marc Jones is taking on the dual role of chief operating officer and chief financial officer at UK point-of-care diagnostics firm Atlas Genetics.
Around 15 medtech companies will benefit from a new $330m fund that has just been raised by investment group LSP. This fund is said to be the biggest in Europe dedicated to medtech.
November may have had the lowest deal volume of the year to date, but five hefty fundraisings pushed the total takings of the first 11 months of 2017 to more than $5.9bn. With one more month to go, will 2017 succeed in surpassing $6bn in total deal value, and claim the title of most bountiful year since 2013?
After knocking Johnson & Johnson off its long-held top position last year, Medtronic has successfully retained the lead in the global medtech market for the second year running in Medtech Insight's MTI 100 rankings. Meanwhile, movement and reshuffling in the ranks continued among other top-tier industry players as they reaped the rewards from previous M&A deals and long-term growth strategies. In this article, we take a closer look at the top-10 overall players, and see who's leapt in front of rivals and who's left eating dust in Medtech Insight's 2017 edition of its annual ranking.
In this edition of Device Week, Tina Tan chats to Marion Webb about the ophthalmic surgical devices market, specifically the smallest but fastest-growing segment of micro-invasive glaucoma surgery (MIGS) devices. Marion gives an insight into some of the emerging players in this space and the feedback from clinicians who have used MIGS devices in their practice.